Jonathan V. Dixon

CIK: 0001967837

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)4 (57.1%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BNGO

Bionano Genomics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

BNGO
Bionano Genomics, Inc.
Aug 3, 2026
Award(A)
Stock Option (Right to Buy)
Direct
15K shares-
BNGO
Bionano Genomics, Inc.
Jun 3, 2026
Tax Payment(F)
Direct
24 shares at avg. $1.30$31.2
BNGO
Bionano Genomics, Inc.
Feb 17, 2026
Tax Payment(F)
Direct
6 shares at avg. $1.10$6.6
BNGO
Bionano Genomics, Inc.
Feb 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
26.1K shares-
BNGO
Bionano Genomics, Inc.
Jun 3, 2025
Tax Payment(F)
Direct
25 shares at avg. $3.69$92.25
BNGO
Bionano Genomics, Inc.
Mar 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
6.6K shares-
BNGO
Bionano Genomics, Inc.
Feb 15, 2025
Tax Payment(F)
Direct
6 shares at avg. $5.73$34.38

		Type	Shares	Price		Ownership
Aug 3, 2026	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	15,000	-	-	Direct
Jun 3, 2026	BNGO Bionano Genomics, Inc.	Tax Payment(F)	24	$1.30	$31	Direct
Feb 17, 2026	BNGO Bionano Genomics, Inc.	Tax Payment(F)	6	$1.10	$7	Direct
Feb 2, 2026	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	26,117	-	-	Direct
Jun 3, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	25	$3.69	$92	Direct
Mar 14, 2025	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	6,559	-	-	Direct
Feb 15, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	6	$5.73	$34	Direct

1-7 of 7 transactions

About Dixon Jonathan V.

Dixon Jonathan V. (SEC CIK 0001967837) files insider reports with the SEC as General Counsel of Bionano Genomics, Inc. (BNGO).

Signal8 holds 8 ownership filings by Dixon Jonathan V. (1 Form 3, 7 Form 4), filed between Feb 19, 2025 and Aug 5, 2026. Those filings report 7 transactions, from Feb 15, 2025 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Dixon Jonathan V.'s filings is in SAN DIEGO, CA.

Recent filings by Dixon Jonathan V.

Aug 3, 2026: Grant or award of BNGO derivative securities (Form 4, code A).
Jun 3, 2026: Tax withholding of BNGO shares (Form 4, code F).
Feb 17, 2026: Tax withholding of BNGO shares (Form 4, code F).
Feb 2, 2026: Grant or award of BNGO derivative securities (Form 4, code A).
Jun 3, 2025: Tax withholding of BNGO shares (Form 4, code F).

Other insiders filing for Bionano Genomics, Inc. (BNGO)

Luderer Albert, Interim Chief Executive
Adamchak Mark, Principal Accounting Officer
OLDAKOWSKI MARK, Chief Operating Officer
Hastie Alex Reid, Chief Scientific Officer
Chaubey Alka, CHIEF MEDICAL OFFICER
Rajkovic Aleksandar, Director

How to read Form 4 transaction codes